Jablonska, Paola AnnaPaola AnnaJablonskaFong, Chin HengChin HengFongKruser, TimothyTimothyKruserWeiss, JessicaJessicaWeissLiu, Zhihui AmyZhihui AmyLiuTakami, HirokazuHirokazuTakamiNarita, YoshitakaYoshitakaNaritaYnoe de Moraes, FabioFabioYnoe de MoraesDasgupta, ArchyaArchyaDasguptaOng, Choo KhoonChoo KhoonOngCHIH-HSIN YANGJIH-HSIANG LEEPavlakis, NicholasNicholasPavlakisKongkham, PaulPaulKongkhamButler, MarcusMarcusButlerShultz, David BDavid BShultz2022-11-042022-11-0420220167-8140https://scholars.lib.ntu.edu.tw/handle/123456789/624441Radiotherapy (RT) and surgery (Sx) are effective in treating brain metastases. However, immune checkpoint inhibitors (ICI) have shown activity against asymptomatic melanoma brain metastases (MBM). BRAF/MEK inhibitors can be used to treat BRAF V600 mutation positive (BRAF+) MBM.enBRAF mutation; Brain metastases; Immunotherapy; Melanoma; Stereotactic radiosurgeryRecommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practicejournal article10.1016/j.radonc.2022.01.037351210332-s2.0-85125366281WOS:000852082500014https://api.elsevier.com/content/abstract/scopus_id/85125366281